News

MIRA Reports Potent Inflammatory Pain Relief from Non-Psychoactive Marijuana Analog Mira-55 in Animal Model, Matching Morphine Without Opioid Risks
MIRA is advancing complementary non-opioid therapies for two of the largest pain markets MIAMI, FLORIDA / ACCESS Newswire / ...
Medical Marketing & Media20h
Omnicom, Achieve design AI-driven launch playbook for smoking cessation product
Credera, Omnicom’s AI and technology unit, will help develop a launch playbook for Achieve Life Sciences’ cytisinicline.
MIRA Pharmaceuticals' Marijuana Analog Mira-55 Shows Potent Pain Relief In Preclinical Study, Stock Jumps 50% After Hours
MIRA Pharmaceuticals (NASDAQ: MIRA) shares soared 50.8% to $1.87 in after-hours trading on Wednesday after announcing promising results for their non-opioid pain drug, Mira-55, and plans for future ...
RealClearPolicy on MSN9hOpinion
Tap Local Law Enforcement to Fight Illicit Flavored Vapes
The Trump administration is cracking down on the flood of illicit flavored e-cigarettes that bad actors are illegally ...
North Coast Journal6h
Ozempic, the Wonder Drug? Part 2
"The medication's going to be 50 percent of your journey, and the other 50 percent is still what you choose to eat and the ...